WP9QY, TNF-a Antagonist – 1 mg

Overview

The WP9QY, TNF-a Antagonist is a specially designed cyclic peptide that mimics the essential tumor necrosis factor (TNF) recognition loop on TNF receptor I. This precise mimicry is crucial as it effectively prevents interactions between TNF and its receptor, making it an invaluable tool for researchers who are studying inflammatory processes and related therapeutic strategies. By inhibiting TNF activity, this peptide can play a significant role in the development of small molecular inhibitors aimed at preventing inflammatory bone destruction and systemic bone loss, particularly in conditions like rheumatoid arthritis.

Key Features

• Mimics the critical TNF recognition loop.
• Inhibits TNF interactions with its receptor.
• Potential for developing small molecular inhibitors.
• Supports research into rheumatoid arthritis treatments.

Specifications

FAQ

What is the primary use of the WP9QY, TNF-a Antagonist?

This peptide is primarily used in research settings to block the interaction between TNF and its receptor, which is critical for studying inflammatory processes.

How does this peptide help in rheumatoid arthritis research?

The WP9QY antagonist is designed to aid in the development of treatments that can prevent bone destruction and loss associated with rheumatoid arthritis, providing a vital tool for researchers in the field.

Can I find other related peptides?

Yes, AnaSpec offers a wide range of peptides that can complement your research needs. You can explore our collection of peptidesincluding various substrates like PKG Substrate and Autocamtide-2.

Related Products

• CREBtide [KRREILSRRPSYR], 5-FAM labeled